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Abstract
Glycemic control is essential for critical care. However, it is a challenging task
because there has been no study on personalized optimal strategies for glycemic
control. This work aims to learn personalized optimal glycemic trajectories for
severely ill septic patients by learning data-driven policies to identify optimal
targeted blood glucose levels as a reference for clinicians. We encoded patient
states using a sparse autoencoder and adopted a reinforcement learning paradigm
using policy iteration to learn the optimal policy from data. We also estimated
the expected return following the policy learned from the recorded glycemic
trajectories, which yielded a function indicating the relationship between real blood
glucose values and 90-day mortality rates. This suggests that the learned optimal
policy could reduce the patients’ estimated 90-day mortality rate by 6.3%, from 31%
to 24.7%. The result demonstrates that reinforcement learning with appropriate
patient state encoding can potentially provide optimal glycemic trajectories and
allow clinicians to design a personalized strategy for glycemic control in septic
patients.
1 Introduction
Many critically ill patients have poor glycemic control, such as dysglycemia and high glycemic
variability. Several studies have investigated the correlation between the management of blood
glucose levels and outcomes in critical care patients [Inzucchi, 2006, Chase et al., 2008, Van den
Berghe et al., 2001, The NICE-SUGAR Study Investigators, 2009]. Current clinical practice follows
the guidelines suggested by the NICE-SUGAR trial for patients in critical care, which targets a blood
glucose level of 100-180 mg/dl [The NICE-SUGAR Study Investigators, 2009]. However, there are
significant variations in clinical conditions and physiological states among patients under critical
care, including disease severity, comorbidity, and other factors that may limit clinicians’ ability to
perform appropriate glycemic control. In addition, clinicians sometimes may not focus on the issue
of glycemic control during patients’ intensive care unit (ICU) stays. To help clinicians better address
the challenge of managing patients’ glucose levels, we need a personalized glycemic control strategy
that can take into account variations in patients’ physiological and pathological states, such as their
degree of insulin dependence and tolerance.
Our goal of decision support for glycemic control is to target specific ranges of serum glucose that
optimize outcomes for patients. These target ranges vary based on patients’ specific circumstances,
and we hypothesize that the patient states, glycemic values, and patient outcomes can be modeled by
a Markov decision process (MDP) whose parameters and optimal policies can be learned from data
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gathered from previous cases. In our approach, we do not try to recommend specific interventions
such as insulin oral hypoglycemic agent administration to achieve the target goals, but focus on
finding the optimal targets. Thus the “action” in our formulation is interpreted as choosing the best
glycemic target under the circumstances, leaving the choice of agents and doses to achieve that target
to the clinicians. This simplification avoids the need to model the variability of patients’ glycemic
responses to actual insulin doses and avoids data problems with incorrectly recorded dose timing.
In this study, we proposed and explored the reinforcement learning (RL) paradigm to learn the policy
for choosing personalized optimal glycemic trajectories using retrospective data. We then compared
the prognosis of the trajectories simulated by following the optimal policy to the real trajectories.
The study overview is shown in Figure 1. We used both direct raw features and features encoded by a
sparse autoencoder to represent patient states, followed by state clustering [Ng, 2011]. Policy iteration
was adopted to learn the optimal policy pi∗ for optimal glycemic trajectories [Howard, 1960]. We
also estimated the policy pir from the real trajectories and obtained the estimated mortality–expected
return function. We then computed the optimal expected return Q∗ using optimal policy pi∗, and used
the function to calculate and compare the estimated mortality rate between the simulated optimal
glycemic trajectories and the trajectories in the real data [Komorowski et al., 2016].
Figure 1: Study overview. Red dot lines indicate the training phase to obtain policies, and blue dashed
lines indicate the testing phase to compute results.
The key contributions of this work include: (a) we explored the effectiveness and validity of using RL
and appropriate representations for learning the policy for optimal glycemic trajectories in different
clinical and physiological states, (b) we applied the method to glycemic control for critical septic
patients, and compared the RL policy-simulated results with real data. Our proposed approach may
enable wider applications in personalized clinical decision making.
2 Related work
RL is a potential approach for sequential decision making with delayed reward or outcome [Nemati
et al., 2016]. RL also has the ability to generate optimal strategies based on non-optimized training
data [Raghu et al., 2017]. Shortreed et al. [2010] investigated the performance of the RL-learned
optimal policy for treatment of schizophrenia. In Nemati et al. [2016], RL is applied to the heparin
dosing problem in critical care using partially observed Markov decision process (POMDP). They
used a discriminative hidden Markov model (DHMM) to estimate the patient states. Prasad et al.
[2017] experimented on using off-policy learning to find the policy for mechanical ventilation
administration and weaning. Komorowski et al. [2016] and Raghu et al. [2017] demonstrated that
optimal strategy of sepsis treatment can be learned by RL algorithms. Komorowski et al. [2016]
applied on-policy learning and evaluated the performance difference between RL agent’s actions
and physicians’ decisions using Q-values. Raghu et al. [2017] worked on the same clinical problem
but introduced a continuous state representation and a deep learning approach with doubly robust
off-policy evaluation [Jiang and Li, 2015]. Related to glycemic control, some studies utilize RL to
design clinical trials and adjust clinical treatments [Asoh et al., 2013, Bothe et al., 2014].
These previous studies focused on giving direct suggestions for clinical intervention and treatment.
To our knowledge, no studies have yet utilized the RL approach to learn better target laboratory values
as references for clinical decision making, such as learning a policy to find personalized optimal
glycemic targets for different patient states.
2
3 Method
Patient State Representation and Clustering Learning a good patient state representation is
important to enable RL algorithms to learn appropriate policies. We experimented with two types of
feature representations: raw interpretable clinical features and the feature representation generated
by a sparse autoencoder [Ng, 2011]. We designed the neural network model with one encoder
and decoder, and extracted the latent representation as 32-dimensional states. The weights of the
sparse autoencoder were computed by backpropagation to minimize the following loss function:
LSparseAE = LAE +β ·Σni=1D · log Dhi +(1−D) · 1−D1−hi , where LAE is the reconstruction loss of the
autoencoder, D is the sparsity distance, h is the latent representation, n is the dimension of the latent
representation, and β is a hyperparameter for sparsity. After we generated the state representation,
we used the k-means clustering algorithm to categorize millions of patient states into 500 clusters
such that similar clinical states can collapse into the same cluster.
Reinforcement Learning and Evaluation The policy iteration algorithm uses dynamic program-
ming and follows the Bellman expectation equation to find the optimal policy pi∗ through two
steps [Howard, 1960, Bellman, 1957], iterative policy evaluation and greedy policy improvement.
Given a current policy pi, reward functionR, transition function P , the current state s and the next
state s′ after taking action a, the threshold for iteration  = 10−4 and the discount factor γ = 0.9, we
iteratively updated state-value functions vk of all states: vk+1(s) =
∑
a∈A pi(a|s)(Ras+γPass′vk(s′)).
Then we returned vpi = vk+1 once |vk+1 − vk| < . Next we used the value function vpi to obtain
a better policy by greedy policy improvement using the Bellman expectation equation as follows:
Qpi(s, a) = Ras + γ
∑
s′∈S Pass′vpi(s′), and pi′(s) = arg maxa∈AQpi(s, a). We used the new policy
pi′ to update new value functions until pi converges to the optimal policy pi∗. The optimal expected
return Q∗ = Qpi
∗
. The algorithm was adopted to learn the optimal policy pi∗, and the real policy
pir from real trajectories, where we limited the action space of each state to only the one with the
highest probability in P instead of exploring all possible actions. pir and real mortality rate were used
to obtain the estimated mortality–expected return function, which reveals the relationship between
expected return and the estimated 90-day mortality rate. We used the function to compute and
compare the estimated mortality rate of real and optimal glycemic trajectories obtain by pir and pi∗.
4 Experiments
Dataset and Patient Cohort We used a large, publicly available ICU database, Medical Infor-
mation Mart for Intensive Care III (MIMIC-III) version 1.4 [Johnson et al., 2016] for the study.
MIMIC-III includes all patients admitted to an ICU at the tertiary medical center, Beth Israel Dea-
coness Medical Center (BIDMC) in Boston, MA from 2001 to 2012. It contains all ICU administrative
data such as service and diagnosis codes, clinical data such as lab and bedside measurements, as well
as the death time (in case of mortality) from the social security database.
Sepsis-3 criteria were adopted to identify patients with sepsis [Singer et al., 2016]. All patients aged
less than 18 years or whose Sequential Organ Failure Assessment (SOFA) score was less than two
were excluded from the study cohort. For the subjects with multiple ICU admissions, only the first
ICU admission was selected in order to ensure the independence of observations. We specifically
separated the patients by correct diabetic status because it is critical to understanding the blood
glucose trajectory. We categorized the patients into diabetic and non-diabetic groups according
to their (1) ICD-9 coding for diabetes (249.* and 250.*), (2) pre-admission glycated hemoglobin
(HbA1c) level with the threshold of 7.0%, (3) admission medications, and (4) the diagnosis of diabetes
in the free text medical history. We removed patients with more than 10% missing values of covariates,
and the final cohort comprised 5,565 patients. Only arterial and venous glucose measurements were
considered due to the issues of accuracy of other measurements [Critchell et al., 2007].
Settings of Reinforcement Learning To decrease the potential for confounding, we considered the
following groups of confounders and encoded them as covariates into the patient states. Patient level
variables: age, gender, admitted ICU unit, SOFA and Elixhauser comorbidity index on admission,
utilization of mechanical ventilator, endotracheal intubation or vasopressor. Blood glucose related
variables: glycated hemoglobin (HbA1c) higher or less than 7 before admission, hyperglycemia and
hypoglycemia events occurred, the first glucose level after admission, and the diabetic status of the
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patient. Periodic vital signs, such as systolic and diastolic blood pressure, respiratory rate, temperature,
heart rate, and SpO2 and Glasgow coma scale (eyes, verbal, motor), as well as laboratory values, such
as arterial blood gas (PO2, PCO2, pH value, total CO2, anion gap), albumin, bicarbonate, calcium,
sodium, potassium, chloride, lactate, creatinine, blood urea nitrogen (BUN), partial thromboplastin
time (PTT), international normalized ratio (INR), CO2, total bilirubin, hemoglobin, hematocrit and
white blood cell count. Data were collected at one hour intervals. We imputed missing values by
linear interpolation of the existing values, and used piecewise constant interpolation if the first or last
observation is missing. All variables were normalized into a zero to one scale for the state encoding.
We used the outcome of interest, 90-day mortality status, as the reward since patients’ survival is
clinicians’ major goal for critical care. A numeric value of +100 was assigned to the end state
for patients who survived 90 days after their admission, and -100 as a penalty for those who were
deceased before 90 days after their admission. The actions were defined by the discretized blood
glucose levels, which were calculated from categorizing continuous glucose levels into 11 bins.
Results In Figure 2, the expected return, which is the rescaled Q∗ learned by the optimal policy
pi∗, is negatively correlated with mortality rate with high correlation. This indicates that the learned
expected return reflects the real patient status well. We computed the empirically estimated mortality
rate of the real glycemic trajectory using the mortality–expected return function acquired from raw
and encoded patient state representations. The average expected 90-day mortality rate of the testing
dataset is 31.00% using the raw feature representation, and 31.08% using the sparse autoencoder
latent representation. Both are close to the mortality rate calculated from the real data (31.17%).
Figure 2: Estimated mortality rate versus expected return computed by the learned policies. (left)
Raw feature representation, (right) 32-dimension sparse autoencoder representation
Using the raw features to learn policy from the real glycemic trajectory, the mean expected return was
10.04, which was consistent with an estimated mortality rate of 31.00%. The optimal policy-simulated
glycemic trajectories had a mean expected return of 36.42, which corresponded to an estimated
mortality rate of 27.29%. Using the latent representations learned by the sparse autoencoder further
reduced the estimated mortality rate to 24.75%. The best optimal policy can potentially reduce the
estimated mortality rate by 6.3% if we choose the appropriate representations (Table 1).
Table 1: Estimated mortality rate of glycemic trajectories simulated by real/optimal policies
Real policy Optimal policy
Representation Expected return Estimated mortality Expected return Estimated mortality
Raw features 10.04 31.00% 36.42 27.29%
Sparse autoencoder 8.75 31.08% 32.49 24.75%
5 Conclusions and Future Works
We utilized the RL algorithm with representation learning to learn the personalized optimal policy for
better predicting glycemic targets from retrospective data. As decision support, this may reduce the
mortality rate of septic patients if clinician-chosen dosages can actually achieve the target glucose
levels chosen by the policy, and thus potentially assist clinicians to optimize the real-time treatment
strategy by providing more accurate treatment goals. Future works include applying a continuous
state space approach, different evaluation methods such as doubly robust evaluation, as well as
applying the method to different clinical decision making problems.
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